glp 1 agonist diabetes GLP-1 Agonists - What is it? Trends in the Development of
Description
It also stopped the transformation of blood glucose into glycogen in muscles
GLP-1R agonist promotes proliferation of neuroendocrine neoplasm cells expressing GLP-1 receptors
Diabetes 70, 25452553 (2021)
1.1 per 1,000 person-years
In contrast, the SOUL trial, which enrolled a higher-risk population, showed a significant reduction in MACE with oral semaglutide [21]
Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes
